Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for TLK286 in advanced ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer; the st…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors [Phase 2]
A Phase 2 trial update evaluating a combination chemotherapy regimen for children with non-testicular malignant germ cell tumors, including …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating topotecan in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors [Phase 1]
Phase 1 trial evaluating combination chemotherapy in previously untreated, newly diagnosed epithelial tumors, including endometrial cancer, …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports results from a completed Phase 2 trial of gefitinib in patients with recurrent or persistent ovarian epithelial cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors [Phase 2]
A Phase 2 trial of ixabepilone in patients with advanced cisplatin-refractory germ cell tumors has completed, evaluating outcomes across cen…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating capecitabine for recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [Phase 2]
Phase 2 trial of aminocamptothecin in recurrent or refractory ovarian epithelial cancer and primary peritoneal cancer completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated the combination of cisplatin and irinotecan in patients with fallopian tube, ovarian, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy [Phase 2]
A Phase 2 trial of oxaliplatin for patients with recurrent or refractory ovarian epithelial cancer or primary peritoneal cancer that did not…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Gefitinib in Treating Patients With Cervical Cancer [Phase 2]
A Phase 2 clinical trial evaluating gefitinib in patients with cervical cancer and related gynecologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
This is a Phase 2 clinical trial update for irofulven in recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer. The …
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update covers the pediatric use of temozolomide in combination with peripheral stem cell transplantation for newly diagn…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer [Phase 2]
This is a Phase 2 clinical trial update of vaccine therapy and biological therapy for advanced cancers across multiple indications, with the…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of carboxyamidotriazole for refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer [Phase 1, Phase 2]
The document reports a completed Phase 1/2 clinical trial evaluating a vaccine therapy plus interleukin-2 in women with advanced breast or o…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 vaccine therapy trial for ovarian, fallopian tube, and primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update on thalidomide for patients with refractory or resistant epithelial ovarian cancer. The trial status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1]
This document reports the completion of a Phase 1 trial evaluating taurolidine in patients with recurrent ovarian epithelial cancer, fallopi…
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer [Phase 2]
This clinical trial update indicates the Phase 2 study of sorafenib tosylate plus gemcitabine hydrochloride in recurrent ovarian epithelial …
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
A clinical trial update summarizes the observed incidence of thromboembolism in patients receiving chemotherapy for solid tumors, across bre…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine and topotecan for refractory or recurrent ovarian cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk [NA]
A clinical trial comparing fenretinide followed by preventive surgery versus preventive surgery alone in women at high risk for ovarian canc…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [Phase 2]
Phase 2 trial update of etoposide in advanced ovarian or cervical cancer has been terminated. The study was sponsored by the Gynecologic Onc…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating liposomal doxorubicin and etoposide in recurrent or persistent ovarian, fallopian tube, or primary peritoneal can…